Recombinant Saccharomyces cerevisiae BAR1 Protein ，His

BAR1 (Bacteriophage Ainsworth Receptor 1) is a significant protein derived from bacteriophages that has garnered attention in the field of molecular biology and biotechnology due to its unique structural and functional properties. Research on BAR1 has primarily focused on its role in bacterial infection processes, where it serves as a receptor for certain phages, facilitating the entrance of viral genetic material into host cells. The interest in BAR1 is heightened by the increasing need for novel antibacterial agents in response to rising antibiotic resistance, making bacteriophage therapy a promising alternative. Studies have shown that BAR1 can be genetically engineered to enhance its specificity and efficacy, potentially leading to tailored phage therapies capable of targeting drug-resistant bacterial strains. Furthermore, understanding the structure-function relationship of BAR1 through advanced techniques like cryo-electron microscopy and X-ray crystallography can unveil mechanisms underlying phage-host interactions, offering insights into the design of new therapeutic strategies. The exploration of BAR1 not only paves the way for innovative applications in clinical settings but also contributes to the broader understanding of microbial ecology and evolution, making it a focal point of ongoing research in both fundamental and applied sciences.